14.10.2016 • News

Reverdia and Xinhuarun to Develop Bio-based PU Foams

(c) AVAVA/Shutterstock
(c) AVAVA/Shutterstock

Dutch biochemicals specialist Reverdia has signed an agreement with China’s Dezhou Xinhuarun Technology to jointly develop and promote microcellular PU foams based on bio-succinic acid. Reverdia’s Biosuccinium will be used in the foams which go into manufacturing footwear, shoe soles and other applications.

Liang Yanzhi, chair of the board at Xinhuarun, said the Dezhou, Shandong-based company will work exclusively with Reverdia. She commented: “Going forward, we will expand our work with Reverdia towards development and commercialization of other sustainable polymers in our strategic markets. These innovative materials address a potential market in excess of $500 million.

A joint venture between Royal DSM and French family-owned firm Roquette Frères, Reverdia is dedicated to the market development of Biosuccinium, which is based on renewable, plant-based resources. Reverdia began licensing the product and technology in 2014.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read